|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Viewpoint |
1 Dorothy M. Davis Heart and Lung Research Institute and
2 Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210
SUMMARY
During the process of heart failure, the myocardium undergoes progressive remodeling. Local proinflammatory cytokines, such as tumor necrosis factor-
, exacerbate the process by promoting chronic inflammation in the heart. Recent evidence indicates that angiotensin II (AII) may participate upstream of and in concert with proinflammatory cytokines to enhance the expression of these cytokines, thus augmenting the remodeling process. Other growth factors, such as leptin, ameliorate the effects of AII and proinflammatory cytokines. Holycross and Radin discuss the antagonistic roles of cytokines in heart failure.
This article has been cited by other articles:
![]() |
J. Z. Guan, T. Maeda, M. Sugano, J.-i. Oyama, Y. Higuchi, T. Suzuki, and N. Makino An Analysis of Telomere Length in Sarcoidosis J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2007; 62(11): 1199 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lamounier-Zepter, M. Ehrhart-Bornstein, P. Karczewski, H. Haase, S. R. Bornstein, and I. Morano Human adipocytes attenuate cardiomyocyte contraction: characterization of an adipocyte-derived negative inotropic activity FASEB J, August 1, 2006; 20(10): 1653 - 1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kovacs, J. Toth, J. Tarjan, and A. Koller Correlation of flow mediated dilation with inflammatory markers in patients with impaired cardiac function. Beneficial effects of inhibition of ACE Eur J Heart Fail, August 1, 2006; 8(5): 451 - 459. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |